Found: 18
Select item for more details and to access through your institution.
Real-world experience with ponatinib therapy in chronic phase chronic myeloid leukemia: impact of depth of response on survival and prior exposure to nilotinib on arterial occlusive events.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00891-x
- By:
- Publication type:
- Article
Hypoalbuminaemia segregates different prognostic subgroups within the refined standard risk acute graft-versus-host disease score.
- Published in:
- British Journal of Haematology, 2018, v. 180, n. 6, p. 854, doi. 10.1111/bjh.15105
- By:
- Publication type:
- Article
Incorporating radiation with anti‐CD19 chimeric antigen receptor T‐cell therapy for relapsed/refractory non‐Hodgkin lymphoma: A multicenter consensus approach.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 1, p. 124, doi. 10.1002/ajh.27155
- By:
- Publication type:
- Article
Translational development of a novel BAFF-R CAR-T therapy targeting B-cell lymphoid malignancies.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 12, p. 4031, doi. 10.1007/s00262-023-03537-w
- By:
- Publication type:
- Article
Impact of hypoalbuminemia on the prognosis of relapsed/refractory B‐cell lymphoma treated with axicabtagene ciloleucel.
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 1, p. 48, doi. 10.1111/ejh.13609
- By:
- Publication type:
- Article
Efficacy of proteasome inhibitor‐based maintenance following autologous transplantation in multiple myeloma: A systematic review and meta‐analysis.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 1, p. 40, doi. 10.1111/ejh.13506
- By:
- Publication type:
- Article
Real‐world experience of carfilzomib‐associated cardiovascular adverse events: SEER‐Medicare data set analysis.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 1, p. 70, doi. 10.1002/cam4.3568
- By:
- Publication type:
- Article
ALL-071: A Phase 4 Study to Evaluate Outpatient Blinatumomab in Patients with Minimal/Measurable Residual Disease (MRD) Positivity (+) of B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S266, doi. 10.1016/S2152-2650(21)01648-7
- By:
- Publication type:
- Article
Poster: ALL-071: A Phase 4 Study to Evaluate Outpatient Blinatumomab in Patients with Minimal/Measurable Residual Disease (MRD) Positivity (+) of B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S209, doi. 10.1016/S2152-2650(21)01308-2
- By:
- Publication type:
- Article
Efficacy of Autologous and Allogeneic Hematopoietic Cell Transplantation in Waldenström Macroglobulinemia: A Systematic Review and Meta-analysis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Allogeneic Hematopoietic Cell Transplantation Is an Effective Treatment for Blastic Plasmacytoid Dendritic Cell Neoplasm in First Complete Remission: Systematic Review and Meta-analysis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Unique characteristics and outcomes of therapy-related acute lymphoblastic leukemia following treatment for multiple myeloma.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 6, p. 1, doi. 10.1038/s41408-022-00680-y
- By:
- Publication type:
- Article
Identification of adult Philadelphia-like acute lymphoblastic leukemia using a FISH‐based algorithm distinguishes prognostic groups and outcomes.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Salvage use of venetoclax-based therapy for relapsed AML post allogeneic hematopoietic cell transplantation.
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor
Targeting chronic lymphocytic leukemia with B‐cell activating factor receptor CAR T cells.
- Published in:
- MedComm, 2024, v. 5, n. 9, p. 1, doi. 10.1002/mco2.716
- By:
- Publication type:
- Article
Impact of bortezomib‐based versus lenalidomide maintenance therapy on outcomes of patients with high‐risk multiple myeloma.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 14, p. 2179, doi. 10.1002/cncr.34778
- By:
- Publication type:
- Article
African Americans with translocation t(11;14) have superior survival after autologous hematopoietic cell transplantation for multiple myeloma in comparison with Whites in the United States.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 1, p. 82, doi. 10.1002/cncr.33208
- By:
- Publication type:
- Article
Age no bar: A CIBMTR analysis of elderly patients undergoing autologous hematopoietic cell transplantation for multiple myeloma.
- Published in:
- Cancer (0008543X), 2020, v. 126, n. 23, p. 5077, doi. 10.1002/cncr.33171
- By:
- Publication type:
- Article